Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

  Out-of-Stock 

Features:

Drug Eluting Coronary Stent

USA Made

Everolimus Drug

Fluoropolymer

Suitable for Diabetic Patients

 
Notify me when available

  • 0
  • Out stock
  • Free

Pay in installments

Choose your plan:

Current plan: 3Month

Description: 30+3

Down payment: $0.00 (25.00%)

Number of payments: 3

Tax: $0.00

Amount of payment: $0.00

Overpayment: $0.00

Total: $0.00

Current plan: Cash

Description: نقدی

Down payment: $0.00 (0.00%)

Number of payments: 1

Tax: $0.00

Amount of payment: $0.00

Overpayment: $0.00

Total: $0.00

 Xience Sierra Everolimus Eluting Coronary Stent

NEW XIENCE SIERRA STENT DESIGN

The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile and greater post-dilatation expansion.

 

XIENCE Sierra for Enhanced Deliverability

 

 

New Stent Delivery System Specifically Designed for Even Your Most Complex Cases

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

 

Unsurpassed Pushability

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

Specifically Designed for the Treatment of Complex Patients

To provide effective treatment in complex lesions during percutaneous coronary intervention (PCI), a stent must be slim so it can get to the lesion, strong to effectively treat challenging vessels, while also offering precise stent placement and deployment. XIENCE Sierra has all three characteristics.

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

 

Slim: Ultra Low Crossing Profile

XIENCE Sierra’s Slim Flex Technology is a key innovation: it enables XIENCE Sierra to have ultra low crossing profile while enhancing the maximum expansion capability. This makes it an ideal choice: 

  •         For tight, calcified lesions
  •         In small, tapered vessels like those in patients with diabetes
  •         For patients best treated via radial access 

SLIM FLEX TECHNOLOGY

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

Strong: Longitudinal Strength, Retention, and Radial Strength

GREATEST LONGITUDINAL STRENGTH

XIENCE Sierra has the greatest longitudinal strength of any drug-eluting stent on the market. When tested for stent compression (shortening of the stent under a 50gf load), XIENCE Sierra demonstrates: 

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

Lower values indicate stronger performance.

 

BEST STENT RETENTION ON THE MARKET

In addition, XIENCE Sierra exhibits market-leading stent retention, which is critical in challenging anatomy. In testing stent retention, data show that XIENCE Sierra is:

  

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

Precise: For Precision Stent Placement

Zero Shortening Upon Deployment

XIENCE Sierra demonstrates 0% stent shortening upon deployment at maximum expansion. This enables the precision in stent placement that is especially critical in complex lesions.

 

100% ACCURATE STENT MARKER PLACEMENT

A key feature for any stent is accurate delivery to the target lesion, and XIENCE Sierra offers 100% accurate stent mid-marker placement so the stent can be precisely aligned with the lesion.

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

The XIENCE Fluoropolymer Stent Coating Promotes Best-in-Class Safety And Healing

In addition to clinical safety, another factor that sets XIENCE apart is the XIENCE fluoropolymer coating. Unlike most other polymers, the fluoropolymer interacts with proteins in the blood in a way that reduces thrombus formation process known as fluoropassivation.

 

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

 

Fluoropolymer Stent vs Bare Metal Stent and Bioabsorbable Polymer Stent

In contrast to the visual above, most stents available today have non-fluorinated surfaces: bioabsorbable polymer stents, durable polymer stents or bare metal stents (BMS). These surfaces interact with proteins in the following ways:

  • The surfaces attract less albumin and more fibrinogen.
  • The fibrinogen, in turn, leads to more platelet adhesion and activation.
  • The platelets, fibrinogen and red blood cells can aggregate and create a thrombus.


Reference : 0

Data sheet

  • Abbott Vascular
  • USA

Specific References

New product



Leave a comment about this product

Write your review

Abbott Vascular - Xience Sierra Everolimus Eluting Coronary Stent

Write your review